SPC146
Obinutizumab í öllum gerðum eins og verndað af grunneinkaleyfinu
Status:
VeittApplication date:
9.2.2016Application published:
15.3.2016Grant published:
15.6.2017
Max expiry date:
23.7.2029Next due date:
30.11.2026Medicine name:
GazyvaroMedicine for children:
No
Timeline
Today
9.2.2016Application
15.3.2016Publication
15.6.2017Registration
4.11.2026Expires
Marketing license
IS authorization number:
EU/1/14/937/001Date:
15.8.2014
Foreign authorization number:
EU/1/14/937Date:
23.7.2014
Owner
Name:
Roche Glycart AGAddress:
Wagistrasse 18, Schlieren-Zuerich CH
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221 Hafnarfirði
Patent
Number:
EP2380910
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 11.9.2024
Expires: 4.11.2025
Payer: Árnason Faktor ehf.
Number: 2
Paid: 15.9.2025
Expires: 4.11.2026
Payer: Árnason Faktor ehf.